Back
Solitario Resources Vs. United Therapeutics Industry Stock Comparison
Sell
14
XPL
Solitario Resources
Last Price:
$0.63
Seasonality Move:
-2.7%
Sell
50
UTHR
United Therapeutics
Last Price:
$290.97
Seasonality Move:
9.4%
Sell
14
Solitario Resources (XPL)
is a Sell
Is Solitario Resources a Buy, Sell or Hold?
-
The current Solitario Resources [XPL] share price is $0.60. The Score for XPL is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
XPL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
50
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy, Sell or Hold?
-
The current United Therapeutics [UTHR] share price is $290.75. The Score for UTHR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XPL Stock Price Chart
What is Solitario Resources's stock price today?
-
The Solitario Resources share price today is $0.60The current trend is relatively stagnant and XPL is experiencing selling pressure, which indicates risk of future bearish movement.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $290.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing slight buying pressure.
XPL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 35.24 | Sell |
Chaikin Money Flow: | -267468 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.61 - 0.67) | Sell |
Bollinger Bands (100): | (0.6 - 0.68) | Sell |
UTHR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.32 | Sell |
Relative Strength Index (14 RSI): | 42.82 | Sell |
Chaikin Money Flow: | 352447 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (290.37 - 321.85) | Sell |
Bollinger Bands (100): | (289.22 - 342.88) | Sell |
XPL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Sell |
20-day SMA: | 0.65 | Sell |
50-day SMA: | 0.63 | Sell |
200-day SMA: | 0.65 | Sell |
8-day EMA: | 0.64 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.64 | Sell |
200-day EMA: | 0.65 | Sell |
UTHR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 285.65 | Buy |
20-day SMA: | 305.94 | Sell |
50-day SMA: | 300.42 | Sell |
200-day SMA: | 339.67 | Sell |
8-day EMA: | 292.48 | Sell |
20-day EMA: | 299.7 | Sell |
50-day EMA: | 305.02 | Sell |
200-day EMA: | 318.86 | Sell |
Solitario Resources Earnings Growth & XPL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.03 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.24 per share, an increase this year of $2.46 per share, and an increase next year of $1.06 per share.
Solitario Resources Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
United Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |